Supplementary Table S4 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry

Supplementary Table S4 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry

<p>Differentially expressed genes by race</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Nadia Mezghani (15055724) (author)
Andere auteurs:	Alexandria Yao (15055727) (author), Daria Vasilyeva (15055730) (author), Nicole Kaplan (15055733) (author), Austin Shackelford (15055736) (author), Angela Yoon (15055739) (author), Elizabeth Phillipone (15055742) (author), Sunil Dubey (15055745) (author), Gary K. Schwartz (15054959) (author), Alison M. Taylor (15055748) (author), Fatemeh Momen-Heravi (10160853) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Therapeutic Research and Development Clinical Research and Trials Head, Neck & Oral Cancers Precision Medicine Translational Research
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Supplementary Table S1 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
door: Nadia Mezghani (15055724)
Gepubliceerd in: (2025)

Supplementary Table S3 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
door: Nadia Mezghani (15055724)
Gepubliceerd in: (2025)

Figure 1 from <i>In Situ</i> Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma
door: Richard C. Gregory (15132698)
Gepubliceerd in: (2025)

Figure 2 from <i>In Situ</i> Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma
door: Richard C. Gregory (15132698)
Gepubliceerd in: (2025)

Figure 3 from <i>In Situ</i> Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma
door: Richard C. Gregory (15132698)
Gepubliceerd in: (2025)

Figure 4 from <i>In Situ</i> Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma
door: Richard C. Gregory (15132698)
Gepubliceerd in: (2025)

Figure 5 from <i>In Situ</i> Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma
door: Richard C. Gregory (15132698)
Gepubliceerd in: (2025)

Table 1 from <i>In Situ</i> Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma
door: Richard C. Gregory (15132698)
Gepubliceerd in: (2025)

Table 2 from <i>In Situ</i> Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma
door: Richard C. Gregory (15132698)
Gepubliceerd in: (2025)

Tables 2 from Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)
door: Simon P. Beyaert (17141915)
Gepubliceerd in: (2025)

Tables 3 from Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)
door: Simon P. Beyaert (17141915)
Gepubliceerd in: (2025)

Supplementary Figure from Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer
door: Sankar Jagadeeshan (15112900)
Gepubliceerd in: (2025)

Supplementary Figures 1 from Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
door: Luana Guimaraes Sousa (16534377)
Gepubliceerd in: (2025)

Supplement 4 from Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial
door: Fei Cao (22247259)
Gepubliceerd in: (2025)

Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
door: Michelle L. Mierzwa (14963463)
Gepubliceerd in: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
door: Bouchra Tawk (15389486)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
door: Glenn J. Hanna (15036909)
Gepubliceerd in: (2025)

Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Table 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Supplementary Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Supplementary Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Supplementary Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Supplementary Figure 4 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
door: Michelle Echevarria (21759856)
Gepubliceerd in: (2025)

Figure S1 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S10 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S11 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S12 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S13 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S14 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S15 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S16 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S17 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S18 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S2 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S3 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S4 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S5 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)

Figure S6 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
door: Keiichi Koshizuka (17078773)
Gepubliceerd in: (2025)